The Need for New Anti-Hepatitis C Virus Therapeutic Strategies : Targeting the cellular micro-ribonucleic acids?
Infection with the hepatitis C virus (HCV) is a worldwide problem. Patients with chronic HCV infection who are non-responders to standard therapy represent a growing population within the HCV epidemic.Novel, more efficient and tolerable therapies are urgently needed. This review discusses the recent...
Main Author: | Elias A Said |
---|---|
Format: | Article |
Language: | English |
Published: |
Sultan Qaboos University
2010-12-01
|
Series: | Sultan Qaboos University Medical Journal |
Subjects: | |
Online Access: | https://journals.squ.edu.om/index.php/squmj/article/view/1518 |
Similar Items
-
Targeting microRNA-122 to Treat Hepatitis C Virus Infection
by: Catherine L. Jopling
Published: (2010-07-01) -
Cellular microRNAs Repress Vesicular Stomatitis Virus but Not Theiler’s Virus Replication
by: Aurélie De Cock, et al.
Published: (2016-03-01) -
The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patients
by: Eman El-Ahwany, et al.
Published: (2016-02-01) -
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease?
by: Giovanni Raimondo, et al.
Published: (2005-04-01) -
Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets
by: Jinghang Xu, et al.
Published: (2020-07-01)